The determinants of the antibiotic resistance process

References

• Grupo Colaborativo Resist NetLa resistencia a los antibióticos en América Latina: importancia de los programas Artemio y Resist NetSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS20003953
   Google Scholar
• SaderHSJonesRNResistencia a los antimicrobianos de los agentes patógenos causantes de infecciones nosocomiales y comunitarias en América Latina: reseña general de las estadísticas de 1997Salvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS20005473
   Google Scholar
• FeferEUso racional de medicamentos: políticas, reglamentación y normas regionalesSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000211219
   Google Scholar
• MurrayBEProblemas y dificultades para controlar el uso de antibióticosSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000220227
   Google Scholar
• AlmeidaFNFor a general theory of health: preliminary epistemological and anthropological notesCad Saúde Pública, Rio de Janeiro2001174753799
   Google Scholar
• RodríguezRSConsumo de antimicrobianos en el hospital: costos y consecuencias del uso y abusoSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000246257
   Google Scholar
• OverbyeKMBarrettJFAntibiotics: where did we go wrong?DDT2005101455215676298
   PubMed Web of Science ®Google Scholar
• HarbarthSSamoreMHAntimicrobial resistance determinants and future controlEmerg Infect Dis200511679480115963271
   PubMed Web of Science ®Google Scholar
• LaxminarayanRBrownGMEconomics of antibiotic resistance: a theory of optimal useJ Environ Econ Manage200142183206
   Web of Science ®Google Scholar
• Vázquez-MorenoEMoreno-SantamaríaRAltagracia-MartínezMKravzov-JinichJRíos-CastañedaCSelf-medication in the Mexican State of VeracruzJ Pharm Finance, Economics and Policy20041324563
   Google Scholar
• Altagracia-MartínezMKravzov-JinichJMoreno-SantamaríaRRíos-CastañedaCVázquez-MorenoEAutomedicación en comunidades rural y urbanas del Estado de Guerrero, MéxicoRevista Mexicana de Ciencias Farmacéuticas20033422735
   Google Scholar
• DreserAWirtzVJCorbettKKEchánizGUso de antibióticos en México: revisión de problemas y políticasSalud Pública Méx2008504480487
   Web of Science ®Google Scholar
• KogutSJSpoonerLMResistance to in-office dispensing of generic antibiotic samplesJ Manag Care Pharm2009151626519125551
   PubMed Web of Science ®Google Scholar
• ConklinMHCulleyEJO’DonnellJCase study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratiosJ Manag Care Pharm2009151556119125550
   PubMed Web of Science ®Google Scholar
• ScottABCulleyEJO’DonnellJEffects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organizationJ Manag Care Pharm200713541241917605512
   PubMed Web of Science ®Google Scholar
• ZhangYHarveyKRational antibiotic use in China: lessons learnt through introducing surgeons to Australian guidelinesAust New Zealand Health Policy2006351616412243
   PubMedGoogle Scholar
• NorrbySRNordCERogerFinchLack of development of new antimicrobial drugs: a potential serious threat to public healthLancet Infect Dis2005511511915680781
   PubMed Web of Science ®Google Scholar
• CosgroveSECarmeliYThe impact of antimicrobial resistance on health and economic outcomesClin Infect Dis20033611433143712766839
   PubMed Web of Science ®Google Scholar
• LarsonELinSXGomez-DuarteCAntibiotic use in Hispanic households, New York CityEmerg Infect Dis2003991096110214519246
   PubMed Web of Science ®Google Scholar
• Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans. World Health Organization. 2002 [cited 2005 Aug 24]; 268: [about 4 p.]. Available from: http://www.who.int/mediacentre/factsheets/fs268/en/print.html.
   Google Scholar
• HardmanJGLimbirdLEMolinoffPBRuddonRWGoodmanGALas bases farmacológicas de la terapéutica9th edMéxico, DFMcGraw-Hill Interamericana200010951121
   Google Scholar
• Salvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000viixi
   Google Scholar
• TortoraJGMicrobiology: an introduction7th edRedwood City, CAThe Benjamín Cummin Publishing Company2001491509
   Google Scholar
• StuartTWMicrobiología6a edMadrid, SpainMcGraw-Hill Interamericana200079111
   Google Scholar
• BlackGJMicrobiology principles and applications6th edNew Jersey, Upper Saddle River, NJPrentice Hall2004356372
   Google Scholar
• IngrahamJLIngrahamCAIntroducción a la microbiología2nd edBarcelona, SpainReverté2002486513
   Google Scholar
• JoklikKWWillettPHAmosBMicrobiología Zinsser20th edBuenos Aires, ArgentinaEditorial Médica Panamericana1998219228
   Google Scholar
• RomeroCRMicrobiología y parasitología humana2nd edMéxico, DFEditorial Médica Panamericana19964050
   Google Scholar
• HeinemannJAHow antibiotics cause antibiotic resistanceDDT19994727910234159
   PubMed Web of Science ®Google Scholar
• KuninCMResistance to antimicrobial drugs-a worldwide calamityAnn Inter Medic19931187557561
   PubMed Web of Science ®Google Scholar
• McCormickJBEpidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogensCurr Opin Microbiol1998112512910066471
   PubMed Web of Science ®Google Scholar
• MacDougallCPolkREAntimicrobial stewardship programs in health care systemsClin Microbiol Rev200518463865616223951
   PubMed Web of Science ®Google Scholar
• BariePSDellingerEPEllnerJJMcGowanJEMaximizing nosocomial infection management with newer therapeutic approaches and techniques in an era of increasing microbial resistance: a surgical perspective2007 [cited 2007 Sept 22]; [about 15 p.]. Available from: http://www.medscape.com/viewprogram/7566_pnt.
   Google Scholar
• WalshCAntibiotics: actions, origins, resistanceWashington, DCASM Press2003320
   Google Scholar
• CapriottiTResistant “superbugs” create need for novel antibioticsDermatol Nurs2007191657017330556
   PubMedGoogle Scholar
• LopezLPLiJZBalanDAHospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infection among hospitalized patients from South America and Mexico: results from a multicenter trialClin Ther20032561846187112860502
   PubMed Web of Science ®Google Scholar
• Final labeling. Synercid® I.V. [cited 2008 Jun 18]; [about 16 p.]. Available from: http://www.fda.gov/cder/foi/label/2008/050748s008,050747s008lbl.pdf.
   Google Scholar
• WrightGDMechanisms of resistance to antibioticsCurr Opin Chem Biol2003756356914580559
   PubMed Web of Science ®Google Scholar
• AppelbaumPCJacobsMRRecently approved and investigational antibiotics for treatment of severe infections, caused by Gram-positive bacteriaCurr Opin Microbiol2005851051716098786
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Index to Drug-Specific Information2009 [cited 2009 Feb 18] Available from: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm.
   Google Scholar
• DrewRHEmerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infectionsPharmacotherapy200727222724917253914
   PubMed Web of Science ®Google Scholar
• Final labeling. Daptomycin (Cubicin®) I.V. [cited 2003 Dec 13]; [about 1 p.]. Available from: http://www.fda.gov/cder/drug/InfoSheets/patient/daptomycinPIS.htm.
   Google Scholar
• Final labeling. Tigecycline (Tygacil®) I.V. [cited 2005 July 27]; [about 1 p.]. Available from: http://www.fda.gov/cder/drug/InfoSheets/patient/tigecyclinePIS.htm.
   Google Scholar
• RasmussenBAGluzmanYTallyFPInhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclinesAntimicrob Agents Chemother1994387165816607526784
   PubMed Web of Science ®Google Scholar
• FDA alert, Linezolid (Zyvox®). Information. [cited 2007 Mar 16]; [about 1 p.]. Available from: http://www.fda.gov/cder/drug/infopage/linezolid/default.htm.
   Google Scholar
• Telithromycin (Ketek®). Information. [cited 2007 Feb 12]; [about 1 p.]. Available from: http://www.fda.gov/cder/drug/infopage/telithromycin/default.htm.
   Google Scholar
• Application number: 21–337. Ertapenem (Invanz®) I.V. or I.M. [cited 2001 Nov 21]; [about 1 p.]. Available from: http://www.fda.gov/cder/foi/nda/2001/21337_Invanz_prntlbl.pdf.
   Google Scholar
• FDA approves new drug to treat complicated urinary tract and intra-abdominal infections. [cited 2007 Oct 17]; [about 1 p]. Available from: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01728.html.
   Google Scholar
• CritchleyIABrownSDTraczewskiMMTillotsonGSJanjicNNational and regional assessment of antimicrobial resistance among community – acquired respiratory tract pathogens identified in a 2005–2006 US faropenem surveillance studyAntimicrob Agents Chemother200751124382438917908940
   PubMed Web of Science ®Google Scholar
• Jagusztyn-KrynickaEKWyszyńskaAThe decline of antibiotic era-new approaches for antibacterial drug discoveryPol J Microbiol2008572919818646395
   PubMed Web of Science ®Google Scholar
• Ertapenem (INVANZ)-A new parenteral carbapenemThe Medical Letter200244W1126A2526
   Google Scholar
• LevySBFactors impacting on the problem of antibiotic resistanceJ Antimicrob Chemother2002491253011751763
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Drug resistance threatens to reverse medical progress. Press Release WHO/41.2000 [cited 2005 Aug 24]; [about 4 p.]. Available from: http://www.essentialdrugs.org/efarmacos/archive/200011/msg00040.php.
   Google Scholar
• ColganRPowersJHAppropriate antimicrobial prescribing: approaches that limit antibiotic resistanceAm Fam Physician2001646999100411578036
   PubMed Web of Science ®Google Scholar
• AnderssonDIPersistence of antibiotic resistant bacteriaCurr Opini Microbiol20036452456
   Web of Science ®Google Scholar
• MckeeganKSBorges-WalmsleyMIWalmsleyARMicrobial and viral drug resistance mechanismsTrends Microbiol20021010S8S1412377562
   PubMed Web of Science ®Google Scholar
• CantrellRYoungAFMartinBCAntibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitisClin Ther200224117018211833830
   PubMed Web of Science ®Google Scholar
• CassellGHEmergent antibiotic resistance: health risks and economic impactFEMS Immunol Med Microbiol1997182712749348162
   PubMedGoogle Scholar
• LipsitchMThe rise and fall of antimicrobial resistanceTrends Microbiol20019943844211553456
   PubMed Web of Science ®Google Scholar
• WiseRHartTCarsOAntimicrobial resistanceBMJ199831771596096109727981
   PubMed Web of Science ®Google Scholar
• BarbosaTMLevySBThe impact of antibiotic use on resistance development and persistenceDrug Resist Updat2000330331111498398
   PubMed Web of Science ®Google Scholar
• JacobsMRStreptococcus pneumoniae: Epidemiology and patterns of resistanceAm J Med20041173A3S15S15360092
   PubMed Web of Science ®Google Scholar
• BergoglioRMAntibióticos5th edBuenos Aires, ArgentinaEditorial Médica Panamericana1993395
   Google Scholar
• MascarettiOABacteria versus antibacterial agents an integrated approachWashington, DCASM Press20038795
   Google Scholar
• RooklidgeSJEnvironmental antimicrobial contamination from terraccumulation and diffuse pollution pathwaysSci Total Environ200432511315144773
   PubMed Web of Science ®Google Scholar
• KonemanEWAllenSDJandaWMSchreckenbergerPCWinnWCDiagnóstico Microbiológico5th edBuenos Aires, ArgentinaEditorial Panamericana1999764832
   Google Scholar
• WhittleGShoemakerNBSalyersAAThe role of bacteroides conjugative transposons in the dissemination of antibiotic resistance genesCell Mol Life Sci20029122044205412568330
   PubMed Web of Science ®Google Scholar
• PooleKMultidrug resistance in Gram-negative bacteriaCurr Opin Microbiol20014550050811587924
   PubMed Web of Science ®Google Scholar
• DavisBDDulbeccoREisenHNGinsbergHSTratado de Microbiología4th edBarcelona, SpainMasson S.A1996198219
   Google Scholar
• DomínguezEZarazagaMSaenzYBrinasLTorresCMechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in SpainMicrob Drug Resist20028432132712523629
   PubMed Web of Science ®Google Scholar
• HoganDKolterRWhy are bacteria refractory to antimicrobials?Curr Opin Microbiol2002547247712354553
   PubMed Web of Science ®Google Scholar
• SanderCCSanderWEResistance to antibacterial agentJung KindDLMortensenJEFraimoroHSCalandraGBAntimicrobial resistance: A crisis in health careNew York, NYPlenum Press19951523
   Google Scholar
• HarbarthSAlbrichWBrun-BuissonCOutpatient antibiotic use and prevalence of antibiotic-resistant Pneumococci in France and Germany: a sociocultural perspectiveEmerg Infect Dis20028121460146712498664
   PubMed Web of Science ®Google Scholar
• DrlicaKThe mutant selection window and antimicrobial resistanceJ Antimicrob Chemother200352111712805267
   PubMed Web of Science ®Google Scholar
• ZhaoXDrlicaKRestricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection windowJ Infect Dis200218556156511865411
   PubMed Web of Science ®Google Scholar
• DrlicaKAntibiotic resistance: can we beat the bugs?DDT200161471411445459
   PubMed Web of Science ®Google Scholar
• DrlicaKZhaoXMutant selection window hypothesis updatedClin Infect Dis200744568168817278059
   PubMed Web of Science ®Google Scholar
• KozyrskyjALDahlMEChateauDGMazowitaGBKlassenTPLawBJEvidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristicsCMAJ2004171213914515262882
   PubMed Web of Science ®Google Scholar
• NicolleLEPreventing infections in non-hospital settings: long-term careEmerg Infect Dis20017220520711294707
   PubMed Web of Science ®Google Scholar
• ButlerCCKinnersleyPProutHRollnickSEdwardsAElwynGAntibiotics and shared decision-making in primary careJ Antimicrob Chemother20014843544011533013
   PubMed Web of Science ®Google Scholar
• AriasMLArtaviaJGonzálezPMongeRAntimicrobial susceptibility pattern of Gram-negative bacterias isolated from enteral feedingRev Biomed2000113169174
   Google Scholar
• Gómez-BarretoDCalderón-JaimesERodríguezREspinosaMLJuárezMcaracterísticas clínico-microbiológicas de la meningitis por Streptococcus pneumoniae resistente a la penicilinaSalud Pública Mex1999415397404
   Google Scholar
• AloushVNavon-VeneziaSSeigman-IgraYCabiliShCarmeliYMultidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impactAntimicrob Agents Chemother2006501434816377665
   PubMed Web of Science ®Google Scholar
• BartlettJGLiteratura Commentary by John GBartlettAntibiotic resistance2007 [cited 2007 July 20]; [about 3 p.]. Available from: http://www.medscape.com.
   Google Scholar
• CoenenSMichielsBVan RoyenPVan der AuweraJCDenekensJAntibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribingBMC Fam Pract200231611011835692
   PubMedGoogle Scholar
• LinderJASingerDEStaffordRSAssociation between antibiotic prescribing and visit duration in adults with upper respiratory tract infectionsClin Ther2003252419243014604741
   PubMed Web of Science ®Google Scholar
• OwensRCFraserGLStogsdillPAntimicrobial stewardship programs as a means to optimize antimicrobial usePharmacotherapy200424789690815303453
   PubMed Web of Science ®Google Scholar
• PedersenGSchonheyderHCSteffensenFHSorensenHTRisk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemiaJ Antimicrob Chemother19994311912610381109
   PubMed Web of Science ®Google Scholar
• BauchnerHSimpsonLChessareJChanging physician behaviour. Leading articlesArch Dis Child20018445946211369556
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance World Health Organization. 2002; [cited 2005 Aug 24]; 194: [about 4 p.]. Available from: http://www.who.int/mediacentre/factsheets/fs194/en/print.html.
   Google Scholar
• AriasIBMezaALResistencia antimicrobiana de Salmonella, Shigella y Vibrio cholerae, Perú 1997–2002Rev Peru Med Exp Salud Publica2004214273275
   Google Scholar
• Van DrielMLDe ShutterADeveugeleMCristianes T. Are sore throat patients who hope for antibiotics actually asking for pain relief?Ann Fam Med20064649449917148626
   PubMed Web of Science ®Google Scholar
• MetlayJPBranasChCFishmanNOHospital-reported Pneumococcal susceptibility to penicillinEmerg Infect Dis2004101545915078597
   PubMed Web of Science ®Google Scholar
• BalabanovaYFedorinIKuznetsovSAntimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?J Antimicrob Chemother20045467367915317742
   PubMed Web of Science ®Google Scholar
• CastroRSicología Médica en México: el último cuarto de sigloRev Mex Sociol2001633271293
   Google Scholar
• SmithRDCoastJAntimicrobial resistance: a global responseBull World Health Organ20028012613311953791
   PubMed Web of Science ®Google Scholar
• KravitsRMeasuring patients’ expectations and requestsAnn Intern Med200113488188811346324
   PubMed Web of Science ®Google Scholar
• MatuzMBenkoRDoroPHajduENagyGNagyEMonnetDLSoosGRegional variations in community consumption of antibiotics in Hungary, 1996–2003Br J Clin Pharmacol20056119610016390356
   PubMed Web of Science ®Google Scholar
• WegenerHCAarestrupFMJensenLGHammerumAMBagerFUse of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in EuropeEmerg Infect Dis19995332933510341169
   PubMed Web of Science ®Google Scholar
• LovineNMBlazerMJAntibiotics in animal feed and spread of resistant Campylobacter from poultry to humansEmerg Infect Dis20041061158115915224671
   PubMed Web of Science ®Google Scholar
• AnguloFJNunneryJABairHDAntimicrobial resistance in zoonotic enteric pathogensRev Sci Tech Off Int Epiz2004232112
   Web of Science ®Google Scholar
• AndersonADNelsonJMRossiterShAnguloFJPublic health consequences of use of antimicrobial agents in food animals in the United StatesMicrob Drug Resist2003937337915000744
   PubMed Web of Science ®Google Scholar
• GerstJDetección de la resistencia a los antibióticos con los sistemas Vitek y Vitek 2 de bioMérieuxSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS20001223
   Google Scholar
• DancerSJHow antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapyLancet Infect Dis2004461161915451489
   PubMed Web of Science ®Google Scholar
• CabelloFCAntibióticos y acuicultura en Chile: consecuencias para la salud humana y animalRev Med Chile20041321001100615478304
   PubMed Web of Science ®Google Scholar
• GayKBaughmanWMillarYThe emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessmentJ Infect Dis20001821417142411023465
   PubMed Web of Science ®Google Scholar
• ZoutmanDEFordBDThe relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen ratesAm J Infect Control20053311515685127
   PubMed Web of Science ®Google Scholar
• Sifuentes-OsornioJDonís-HernándezJLas redes de estudio de la resistencia bacteriana ¿son realmente necesarias?Salvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000811
   Google Scholar
• SosaALa alianza para el uso prudente de los antibióticos. Resistencia a los antibióticos en América LatinaSalvatierra-GonzálezRBenguiguiYResistencia antimicrobiana en las Américas: Magnitud del problema y su contenciónWashington, DCOPS/OMS2000258260
   Google Scholar
• BreilhJNuevos conceptos y técnicas de Investigación. Guía pedagógica para un taller de metodologíaQuito, EcuadorCentro de Estudios y Asesoría en Salud19941957
   Google Scholar
• AvornJLBarrettJFMcEwenSAO’BrienTFLevySBAntibiotic resistance synthesis of recommendations by expert policy groups Geneva, SwitzerlandWorld Health Organization20011163
   Google Scholar
• Madaras-KellyKOptimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistancePharmacotherapy200323121627163314695042
   PubMed Web of Science ®Google Scholar
• GleckmanRASelected issues in antibiotic resistanceInfect Med2004213114122
   Google Scholar
• ZaidiMSifuentes-OsornioJRolónALInadequate therapy and antibiotic resistance risk factors for mortality in the intensive care unitArch Med Res200233329029412031636
   PubMed Web of Science ®Google Scholar
• GotfriedMHEpidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999–2000 respiratory surveillance programAm J Med20011119A25S29S11755440
   PubMed Web of Science ®Google Scholar
• FinkelsteinJADavisRLDowellSFreducing antibiotic use in children: a randomized trial in 12 practicesPediatrics200110811711433046
   PubMed Web of Science ®Google Scholar
• KollefMHInadequate antimicrobial treatment: an important determinant of outcome for hospitalized patientsClin Infect Dis200031Suppl 4S131S13811017862
   PubMed Web of Science ®Google Scholar
• CourvalinPAntimicrobial drug resistance: “prediction is very difficult, especially about the future”Emerg Infect Dis2005111015031506
   Web of Science ®Google Scholar
• AndrésJCAndrésNFFornosJAEvaluación de la intervención farmacéutica sobre cumplimiento en terapia antibióticaSeguim Farmacoter20042297102
   Google Scholar